19.07.2011 • News

Roche to Acquire 100% Of Privately-held mtm Laboratories

Ventana Medical Systems, a member of the Roche, said Roche has signed an agreement under which it will acquire 100% of mtm laboratories, a privately-held company based in Heidelberg, Germany.

As per the terms of the agreement, Roche will pay mtm shareholders an upfront payment of around €130 million, or $180 million, as well as up to approximately €60 million, or $85 million, upon reaching performance-related milestones.

The transaction is subject to customary closing conditions and is expected to close in the coming weeks.

 

Company

F. Hoffmann-La Roche Ltd


4070 Basel
Switzerland

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.